New anti-complement therapy to reduce reperfusion injury: phase II
Ended Project Grant Awarded Last action
- Award ID
- R42HL079855
- Recipient
-
Endoprotech Inc. UEI TGWXNHCYTTR3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $963,666
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Louisville, KY 40204, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $464,776 | |
| Original award | $498,890 |
Quick answers
Who received award R42HL079855?
R42HL079855 was awarded to Endoprotech Inc. by National Institutes of Health (Department of Health and Human Services) on May 1, 2005.
How much is award R42HL079855 worth?
$963,666 has been obligated on R42HL079855.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award